Subcutaneous Secukinumab Relieves Psoriatic Arthritis Subcutaneous Secukinumab Relieves Psoriatic Arthritis

The interleukin-17A inhibitor is effective and safe, according to first results from the ongoing FUTURE5 study, the largest controlled trial of a biologic for psoriatic arthritis to date.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Rheumatology News Source Type: news